Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-16
SponsorUniversity Hospital, Montpellier
About this trial
In this study, a selective and multi-stages screening for neurodevelopmental disorders (NDD) in siblings of children with a confirmed ASD is done. The main aims are to estimate the prevalence of NDD among siblings and to evaluate the feasibility and acceptability of a standardized screening procedure.
Eligibility criteria
Qualifiers
Step 1: Brothers or sisters (including stepsisters and brothers); aged between 2 and 16 years; living in Occitanie; informed and express consent of parents ; affiliated to social security.
Step 2: step 1 positive screening or parental concerns for child's development ; parental signed informed consent.
Disqualifiers
Parents (or child) refusal to participate; adopted brother or sister. Do not speak French
Trial design
Treatments tested in this trial
- Step 1 - Screening ; Step 2 - Clinical interview
Treatment groups
384 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital, Montpellier
Lead sponsor
Direction Générale de l'Offre de Soins
Collaborator
Source ClinicalTrials.gov